Citadel Advisors
MDCX

Citadel Advisors’s Medicus Pharma MDCX Stock Holding History

Citadel Advisors’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2K Buy
25,102
+7,278
+41% +$2.58K ﹤0.01% 13489
2026
Q1 		$8.18K Buy
+17,824
New +$18.6K ﹤0.01% 12781
2025
Q3 		– Sell
-41,099
Closed -$123K – 14472
2025
Q2 		$123K Buy
+41,099
New +$164K ﹤0.01% 11143

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Citadel Advisors's MDCX Position: Q2 2026 in Review

Citadel Advisors increased its Medicus Pharma (MDCX) stake by 41% in Q2 2026, buying an estimated $2.58K and bringing the position to 25,102 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #13489.

Citadel Advisors first reported a position in MDCX in Q2 2025 and has held it in 3 quarters since. The position peaked at $123K in Q2 2025. 24 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Citadel Advisors held 25,102 shares of Medicus Pharma worth $11.2K as of Q2 2026.
  • Citadel Advisors bought 7,278 Medicus Pharma shares in Q2 2026, an estimated $2.58K.
  • Medicus Pharma made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13489 holding.
  • Citadel Advisors first reported a position in Medicus Pharma in Q2 2025 and has held it in 3 quarters since.
  • Citadel Advisors's Medicus Pharma position peaked at $123K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.